Hasan ÖZEN, Hülya DEMİR, Aysel YÜCE, Yusuf AYDEMİR, Kader Karlı OĞUZ, Figen GÜRAKAN, Meral TOPÇU, İnci Nur Saltık TEMİZEL, Dilek YALNIZOĞLU

Evaluation of central nervous system in patients with glycogen storage disease type 1a

Aydemir Y, Gürakan F, Saltık-Temizel İN, Demir H, Karlı-Oğuz K, Yalnızoğlu D, Topçu M, Özen H, Yüce A. Evaluation of central nervous system in patients with glycogen storage disease type 1a. Turk J Pediatr 2016; 58: 12-18. We aimed to evaluate structure and functions of central nervous system (CNS) in children with glycogen storage disease (GSD) type 1a.Neurological examination, psychometric tests, electroencephalography (EEG), magnetic resonance imaging (MRI), visual evoked potentials(VEP) and brainstem auditory evoked potentials (BAEP) were performed. The results were compared between patients with good and poor metabolic control and healthy children.Twenty-three patients with GSD type 1a were studied. Twelve patients were in poor metabolic control group and 11 patients in good metabolic control group. Five patients had intellectual disability, 10 had EEG abnormalities, seven had abnormal VEP and two had abnormal BAEP results. MRI was abnormal in five patients. There was significant correlation between the number of hypoglycemic attacks and MRI abnormalities. Central nervous system may be affected in GSD type 1a even in patients with normal neurologic examination. Accumulation of abnormal results in patients with poor metabolic control supports the importance of metabolic control in GSD type 1a

PDF

___

1. Chen YT. Glycogen storage diseases. In: Scriver CR, Beaudet AL, Sly WS, Vale D (eds). The Metabolic and Molecular Basis of Inherited Disease (8th ed). New York: McGraw-Hill; 2001: 1521-1551.
2. Cori GT, Cori CF. Glucose-6-phosphatase of the liver in glycogen storage disease. J Biol Chem 1952; 199: 661-667.
3. van Schaftingen E, Gerin I. The glucose-6-phosphatase system. Biochem J 2002; 362: 513-532.
4. Wolfsdorf JI, Weinstein DA. Glycogen storage diseases. Rev Endocr Metab Disord 2003; 4: 95-102.
5. Froissart R, Piraud M, Boudjemline A M et al. Glucose- 6-phosphatase deficiency. Orphanet J Rare Dis 2011; 6: 27.
6. Rake JP, Visser G, Labrune P, et al. Guidelines for management of glycogen storage disease type I - European Study on Glycogen Storage Disease Type I (ESGSD I). Eur J Pediatr 2002; 161: S112-S119.
7. Weinstein DA, Wolfsdorf JI: Effect of continuous glucose therapy with uncooked cornstarch on the long-term clinical course of type 1a glycogen storage disease. Eur J Pediatr 2002; 161: S35-S39.
8. Rake JP, Visser G, Labrune P, et al. Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease Type I (ESGSD I) Eur J Pediatr 2002; 161: S20–S34.
9. Narisawa K, Igarashi Y, Otomo H, et al. A new variant of glycogen storage disease type I probably due to a defect in the glucose-6-phosphate transport system. Biochem Biophys Res Commun 1978; 83: 1360-1364.
10. Wechsler D. Manual for the Wechsler Intelligence Scale for Children. New York, Psychological Corporation, 1974.
11. Mergenthaler P, Lindauer U, Dienel GA, et al. Sugar for the brain: the role of glucose in physiological and pathological brain function. Trends Neurosci 2013; 36: 587–597.
12. Melis D, Parenti G, Della Casa R, et al. Brain damage in glycogen storage disease type I. J Pediatr 2004; 144: 637-642.
13. Talente GM, Coleman RA, Alter C, et al. Glycogen storage disease in adults. Ann Intern Med 1994; 120: 218-226.
14. Pramming S, Thorsteinsson B, Stigsby B, et al. Glycaemic threshold for changes in electroencephalograms during hypoglycaemia in patients with insulin dependent diabetes. Br Med J 1988; 296: 665-667.
15. Sannita WG, Fatone M, Garbarino S, et al: Effects of physiological changes of serum glucose on the patternVEP of healthy volunteers. Physiol Behav 1995; 58: 1021-1026.
16. Koh TH, Aynsley-Green A, Tarbit M, et al. Neural dysfunction during hypoglycaemia. Arch Dis Child 1988; 63: 1353-1358.
17. Barkovich AJ, Ali FA, Rowley HA, et al. Imaging patterns of neonatal hypoglycemia. Am J Neuroradiol 1998; 19: 523-528.
18. Murakimi Y, Yamashita Y, Matsuishi T, et al. Cranial MRI of neurologically impaired children suffered from neonatal hypoglycaemia. Pediatr Radiol 1999; 29: 23- 27.
19. Burns CM, Rutherford MA, Boardman JP, et al. Patterns of cerebral injury and neurodevelopmental outcomes after symptomatic neonatal hypoglycemia. Pediatrics 2008; 122: 65-74.
20. Aoki T, Sato T, Hasegawa K, et al. Reversible hyperintensity lesion on diffusion weighted MRI in hypoglycemic coma. Neurology 2004; 63: 392-393.
21. Kim JH, Roh JH, Koh SB. Reversible injury of internal capsule and splenium in a patient with transient hypoglycemic hemiparesis. Cerebrovasc Dis 2006; 22: 282-283.
22. Lo L, Tan AC, Umapathi T, et al. Diffusion weighted MR imaging in early diagnosis and prognosis of hypoglycemia. AJNR Am J Neuroradiol 2006; 27: 1222-1224.